Biotech News Alert: GenSpera (OTCQB:GNSZ) Announces Generic Name “Mipsagargin” for Lead Drug Candidate G-202 per Recommendation by World Health Organization
Mipsagargin Contains New Pre-Stem “Gargin”, Defining a Unique Pharmacologic Group Unlike Any Drug Currently or Previously on the Market
SAN ANTONIO, Texas, September 3, 2014 – (Investorideas.com Biotech Newswire) GenSpera, Inc. ( ... Read more